E-drug: Heptitis-B vaccines and their comparison
------------------------------------------------
Dear e-druggers,
Now-a-days, in Pakistan, the market is flooded with various types of
vaccines for prevention of Hepatitis-B infection. Each one seems to
claim better safety, efficacy and immunogenecity. In fact there is
quite a difference in prizes of the products produced by multinational
from UK and Korea.
It is very necessary to know how these vaccines differ in their efficacy
and cost-effectiveness. Can any of the e-druggers please help or guide
me how to go about it. This can have a long term implication as far as
national policy decision is concerned.
Waiting anxiously,
Prof. Dr. Inayat Thaver,
Public Health Scientist,
Karachi, Pakistan
Email: thaver@khi.compol.com
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to: `owner-e-drug@usa.healthnet.org'.